Status:
COMPLETED
Effect of Midazolam Premedication on Opioid-induced Mask Ventilation Difficulty
Lead Sponsor:
Karaman Training and Research Hospital
Conditions:
Anesthesia Complication
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Mask ventilation has great importance during anesthesia induction because it is the only way to oxygenate patients who have lost consciousness and spontaneous breathing. Opioid-derived drugs used in a...
Detailed Description
American Society of Anesthesiologists (ASA) class I and II patients who are admitted to undergoing elective surgery under general anesthesia will be enrolled. Patients in midazolam group (Group M) wil...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) class I and II patients
- Patients who are scheduled for any elective surgery under general anesthesia
Exclusion
- age \<18 or \>60 years
- current cervical spine disease or history of cervical spine surgery;
- morbid obesity (body mass index, ≥35 kg/m2);
- sleep apnea;
- craniofacial anomaly;
- allergic reaction to midazolam and remifentanil
- chronic use of opioid, benzodiazepine, antipsychotic medications
- pregnancy
- presence of muscle weakness or dyspnea
Key Trial Info
Start Date :
May 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 3 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05369819
Start Date
May 24 2022
End Date
January 3 2024
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karaman Training and Research Hospital
Karaman, Turkey (Türkiye)